http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2007040082-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-16 |
filingDate | 2006-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2007040082-A1 |
titleOfInvention | Pharmaceutical composition for treating or preventing nephritis and method for producing the same |
abstract | The nephritis treatment composition of the present invention comprises a triprenylphenol compound as an active ingredient, preferably a triprenylphenol compound represented by the following general formula (I) as an active ingredient, and in particular, n in the following general formula (I): It is preferable to use orniprabin represented by = 3 as an active ingredient. [Chemical 1] (In the formula, n represents an integer of 1 to 10.) Moreover, the manufacturing method of the pharmaceutical composition for the treatment or prevention of nephritis of this invention includes using a triprenyl phenol compound as an active ingredient. |
priorityDate | 2005-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 141.